Shengtai Pharmaceutical, Inc. Share Price

Equities

SGTI

US8232142005

Pharmaceuticals

Market Closed - OTC Markets 06:40:00 12/12/2023 am IST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Shengtai Pharmaceutical, Inc. -.--% -.--%
Sales 2011 172M 14.33B Sales 2012 179M 14.94B Capitalization 14.86M 1.24B
Net income 2011 7M 584M Net income 2012 1M 83.46M EV / Sales 2011 0.4 x
Net Debt 2011 55.79M 4.66B Net Debt 2012 86.75M 7.24B EV / Sales 2012 0.57 x
P/E ratio 2011
1.63 x
P/E ratio 2012
14.1 x
Employees -
Yield 2011 *
-
Yield 2012
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0
0.03
5 years
0.00
Extreme 0
0.04
10 years
0.00
Extreme 0
0.30
More quotes
Managers TitleAgeSince
Chairman 65 -
Director/Board Member 54 01/06/01
Members of the board TitleAgeSince
Chairman 65 -
Director/Board Member 54 01/06/01
Director/Board Member - -
More insiders
Shengtai Pharmaceutical, Inc. (Shengtai), through its wholly owned subsidiary, Weifang Shengtai Pharmaceutical Inc., is a producer of pharmaceutical-grade glucose in China. The Company's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The Company's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The Company's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The Company also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.
More about the company